Found 0 matching trials
Eltanexor (KPT-8602) With Inqovi (Decitabine-Cedazuridine) in High-Risk Myelodysplastic Syndromes PHASE1 Background:
Myelodysplastic syndromes (MDS) are diseases that affect the b...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia (AML) Following Initial Treatment PHASE2 ERASE is part of the MyeloMATCH initiative, Young Adult Basket and is a Tie...
Show More Location
Multiple Locations
Learn More & Join Trial
A Dose-Finding and Efficacy Study of Venetoclax, CC-486, and Obinutuzumab in Follicular Lymphoma PHASE1 This study focuses on finding a safe and tolerable dose for a three-drug re...
Show More Location
University of Chicago Medical Center
Learn More & Join Trial
Epigenetic Reprogramming in Relapse/Refractory AML PHASE1 This is a pilot study using decitabine and vorinostat before and during che...
Show More Location
Children's Hospital Los Angeles
Learn More & Join Trial
A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia PHASE1 This research study is studying a targeted therapy known as GO-203-2C as a ...
Show More Location
Dana-Farber Cancer Institute
Learn More & Join Trial
Azacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206) PHASE1 This is an open-label, Phase 1/2 study in subjects with advanced or metasta...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial
Dose-Escalation Study of E7727, an Oral Cytidine Deaminase Inhibitor With Oral Decitabine in Subjects With Solid Tumors PHASE1 This is a phase 1 study of the combination of cedazuridine with decitabine ...
Show More Status
Active Not Recruiting
Location
USC Norris Comprehensive Cancer Center
Learn More & Join Trial
Venetoclax in Combination With Azacitidine (VEN/AZA) Followed by Donor Lymphocyte Infusion (DLI) for Patients With Very High-Risk Acute Myeloid Leukemia (AML) Undergoing Allogeneic Hematopoietic Cell Transplant (HCT) PHASE1 The purpose of this study is to see the effects of an investigational combi...
Show More Location
University of Miami
Learn More & Join Trial
HEM-iSMART-A: Decitabine / Venetoclax and Navitoclax in Pediatric Patients With Relapsed or Refractory Hematological Malignancies PHASE1 HEM-iSMART is a master protocol which investigates multiple investigational...
Show More Location
Princess Máxima Center for Pediatric Oncology
Learn More & Join Trial
Study of Vosaroxin With Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome With Excess Blasts-2 PHASE2 The main part of this trial is a phase II study of vosaroxin with azacitidi...
Show More Location
Kliniken Essen-Süd, Evang. Krankenhaus Essen-Werden gGmbH
Learn More & Join Trial